Egyptian International Pharmaceuticals (EIPICO)
Egyptian International Pharmaceuticals (EIPICO) operates in various business sectors.
Egyptian International Pharmaceuticals (EIPICO) (PHAR) - Net Assets
Latest net assets as of : EGP- EGP
Based on the latest financial reports, Egyptian International Pharmaceuticals (EIPICO) (PHAR) has net assets worth EGP- EGP as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (EGP-) and total liabilities (EGP-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | EGP- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Egyptian International Pharmaceuticals (EIPICO) - Net Assets Trend (None–None)
This chart illustrates how Egyptian International Pharmaceuticals (EIPICO)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Egyptian International Pharmaceuticals (EIPICO) (None–None)
The table below shows the annual net assets of Egyptian International Pharmaceuticals (EIPICO) from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Egyptian International Pharmaceuticals (EIPICO)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Egyptian International Pharmaceuticals (EIPICO) Competitors by Market Cap
The table below lists competitors of Egyptian International Pharmaceuticals (EIPICO) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BLAU3F
SA:BLAU3F
|
$15.46K |
|
SHINE TREND International Multimedia Technology CO., LTD.
TWO:6856
|
$15.47K |
|
Scancell Hldgs Plc
LSE:SCLP
|
$15.47K |
|
GREAT WALL MOTOR-H-
BE:GRV
|
$15.47K |
|
CPTL & COUNT PROP
BE:C20
|
$15.45K |
|
OPERA SOFTWARE
MU:OS3
|
$15.45K |
|
Cresud Wnt
BA:CRE3W
|
$15.44K |
|
Ceylon Graphite Corp
PINK:CYLYF
|
$15.43K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Egyptian International Pharmaceuticals (EIPICO)'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Egyptian International Pharmaceuticals (EIPICO)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Egyptian International Pharmaceuticals (EIPICO) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Egyptian International Pharmaceuticals (EIPICO)'s net assets metrics with peer companies in the same industry.
No peer company data available for comparison.